Clarius Mobile Health gets US FDA clearance for Clarius OB AI fetal biometric measurement tool

Canada-based Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, has obtained US FDA clearance for the Clarius OB AI foetal biometric measurement tool, improving access to obstetrical (OB) prenatal monitoring and care in resource-limited areas.

The OB AI model automatically performs foetal biometry measurements to estimate fetal age, weight and growth intervals and is available now with the Clarius C3 HD3 wireless handheld ultrasound scanner in the United States and Canada.

Developed with state-of-the-art deep learning models leveraging more than 30,000 de-identified foetal ultrasound images, Clarius OB AI provides consistent and precise measurements enabling new ultrasound users, including midwives and nurses, the ability to perform accurate fetal ultrasound measurements with confidence. By integrating AI with affordable and specialised ultrasound technology, Clarius aims to broaden ultrasound access for midwives and nurses, to help improve maternal and fetal health outcomes.

Once activated on the Clarius app while a clinician is scanning the abdomen, OB AI automatically highlights key fetal anatomy and places calipers to calculate measurements, which appear on screen and can be added to a patient's electronic record from the app. Clarius OB AI is the 8th AI model developed in-house that is available with Clarius ultrasound scanners.